Table 3.
Covariate Summary
| Baseline Covariates | celecoxib (N=4,606) | NSAID (N=17,175) |
|---|---|---|
| Age (mean) | 60.7 | 55.2 |
| Sex (female) | 61.2% | 60.2% |
| Rheumatoid Arthritis | 2.9% | 1.2% |
| Osteoarthrosis | 27.8% | 12.9% |
| Backache | 24.1% | 17.0% |
| Chest pain | 15.0% | 12.2% |
| Osteoporosis | 4.0% | 2.1% |
| Atrial fibrillation | 9.1% | 5.7% |
| Abdominal pain | 21.5% | 17.1% |
| Peptic ulcer, GERD, or Esophageal ulcer |
10.7% | 7.3% |
| Heart disease | 20.6% | 15.5% |
| Hypertension | 40.3% | 32.8% |
| PPI | 14.8% | 9.7% |
| Warfarin use | 6.5% | 3.4% |
| Pain | 32.5% | 22.3% |
| Six or more prescription drugs in prior year |
69.8% | 57.9% |